PHASE-3 STUDIES WITH ETOPOSIDE (VP16-213) IN LUNG-CANCER PATIENTS

被引：0
作者：
ISSELL, BF [1 ]
ROSENBAUM, PF [1 ]
DHAFIR, RA [1 ]
机构：
[1] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
[41]   VP16-213 IN COMBINED MODALITY TREATMENT OF SMALL CELL-CARCINOMA OF THE LUNG [J].
NEWMAN, SB ;
BITRAN, JD ;
GOLOMB, HM ;
HOFFMAN, PC ;
DEMEESTER, TR ;
RAGHAVAN, V .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (04) :343-346
[42]   PHASE-II TRIAL OF VP-16-213 IN NON-SMALL-CELL LUNG-CANCER [J].
ITRI, LM ;
GRALLA, RJ ;
CHAPMAN, RA ;
KELSEN, DP ;
CASPER, ES ;
GOLBEY, RB .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01) :45-47
[43]   PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER [J].
MATSUI, Y ;
OSHIMA, S ;
KADO, M ;
NAKAYAMA, M ;
SHIMOKATA, K ;
SAKAI, S ;
ITO, F ;
CHIKATA, E ;
HARA, K ;
KANDA, T ;
SHIMA, K ;
TAKENAKA, S ;
HOKAMA, S ;
GENGA, K .
CANCER, 1987, 60 (12) :2882-2885
[44]   REVERSED SENSITIVITY TO ANTICANCER DRUGS VP16-213 (ETOPOSIDE) AND MITOMYCIN-C BY HUMAN-LUNG CARCINOMA CELL-LINES [J].
MUSIAL, ST ;
BRATTAIN, MG ;
LONG, BH .
FEDERATION PROCEEDINGS, 1985, 44 (04) :1144-1144
[45]   VP-16-213 - A PHASE-II STUDY OF NON-SMALL CELL LUNG-CANCER (NSCLC) [J].
ITRI, LM ;
GRALLA, RJ ;
KELSEN, DP ;
CHAPMAN, RA ;
GOLBEY, RB ;
KAUFMAN, RJ ;
YOUNG, CW .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR) :199-199
[46]   ETOPOSIDE (VP16-213) AND TENIPOSIDE (VM26) COMPARATIVE INVITRO ACTIVITIES IN HUMAN-TUMORS [J].
ISSELL, BF ;
TIHON, C ;
CURRY, ME .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :113-115
[47]   MONO AND COMBINATION CHEMOTHERAPY WITH VP 16-213 IN SMALL CELL LUNG-CANCER (SLC) [J].
BRUNNER, K ;
JUNGI, W .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR) :308-308
[48]   CISPLATIN AND ETOPOSIDE (VP-16) AS A SINGLE REGIMEN FOR SMALL CELL LUNG-CANCER - A PHASE-II TRIAL [J].
BONI, C ;
COCCONI, G ;
BISAGNI, G ;
CECI, G ;
PERACCHIA, G .
CANCER, 1989, 63 (04) :638-642
[49]   HIGH-DOSE ETOPOSIDE (VP-16) IN SMALL-CELL LUNG-CANCER [J].
GRECO, FA ;
JOHNSON, DH ;
HANDE, KR ;
PORTER, LL ;
HAINSWORTH, JD ;
WOLFF, SN .
SEMINARS IN ONCOLOGY, 1985, 12 (01) :42-44
[50]   EFFECT OF ETOPOSIDE (VP16-213) ON LIPID-PEROXIDATION AND ANTIOXIDANT STATUS IN A HIGH-DOSE RADIOCHEMOTHERAPY REGIMEN [J].
LADNER, C ;
EHNINGER, G ;
GEY, KF ;
CLEMENS, MR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (03) :210-212
12345